Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...

A new study says the flu A viral strain can adapt shape to stay infectious. Infectious disease doctors break down what this means and how to protect yourself.

The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ... Influenza A Viruses Adapt Shape in Response to Environmental Pressures Feb. 10, 2025 — Influenza A virus ...

WOBURN, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...

MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

Cells were fixed with 10% formaldehyde and plaques were visualized and their counts were estimated with crystal violet staining and subjected to statistical analysis. Vaccinia virus particles were ...